secwatch.observer — SEC 8-K summary
======================================

Issuer:     Instil Bio, Inc. (TIL)
CIK:        0001789769
Form:       8-K
Filed at:   2026-01-06T23:59:59+00:00
Accession:  0001789769-26-000004
Event type: other_material
Sentiment:  negative
Materiality: 0.60
Item codes: 1.02
LLM model:  deepseek-v4-flash:cloud@v2

Instil Bio subsidiary terminates license deal with ImmuneOnco for AXN-2510 and AXN-27M
--------------------------------------------------------------------------------

- Axion Bio (Instil Bio subsidiary) terminated License and Collaboration Agreement with ImmuneOnco effective Jan 5, 2026.
- Agreement, dated Aug 1, 2024, granted Axion ex-China rights to AXN-2510 and AXN-27M.
- No details provided on termination reason or financial impact on Instil Bio.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1789769/000178976926000004/0001789769-26-000004-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1789769/000178976926000004/til-20260105.htm
  HTML page:      https://secwatch.observer/filing/0001789769-26-000004

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer